These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26094833)
1. A survey of UK practice patterns in the delivery of intravitreal injections. Samia-Aly E; Cassels-Brown A; Morris DS; Stancliffe R; Somner JE Ophthalmic Physiol Opt; 2015 Jul; 35(4):450-4. PubMed ID: 26094833 [TBL] [Abstract][Full Text] [Related]
2. [Results of an expert survey on VEGF inhibitors in ophthalmology]. Kühn T Klin Monbl Augenheilkd; 2011 Jul; 228(7):607-12. PubMed ID: 21472638 [TBL] [Abstract][Full Text] [Related]
3. Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis. Buck DA; Dawkins R; Kawasaki R; Sandhu SS; Allen PJ Clin Exp Ophthalmol; 2015 Apr; 43(3):277-9. PubMed ID: 25112536 [No Abstract] [Full Text] [Related]
4. Experience of New Brunswick ophthalmologists using intravitreal anti-vascular endothelial growth factor. Giberson M; Taylor V Can J Ophthalmol; 2015 Oct; 50(5):393-4. PubMed ID: 26455977 [No Abstract] [Full Text] [Related]
5. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada. Xing L; Dorrepaal SJ; Gale J Can J Ophthalmol; 2014 Jun; 49(3):261-6. PubMed ID: 24862772 [TBL] [Abstract][Full Text] [Related]
6. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV). Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal injections: is there benefit for a theatre setting? Abell RG; Kerr NM; Allen P; Vote BJ Br J Ophthalmol; 2012 Dec; 96(12):1474-8. PubMed ID: 23018424 [TBL] [Abstract][Full Text] [Related]
8. GMC is criticised for refusing to disclose reasons behind its advice to support prescribing for Lucentis rather than Avastin for wet AMD. Cohen D BMJ; 2015 Apr; 350():h1981. PubMed ID: 25869865 [No Abstract] [Full Text] [Related]
9. Off-label prescribing in macular degeneration. McCartney M BMJ; 2011 Oct; 343():d6778. PubMed ID: 22012651 [No Abstract] [Full Text] [Related]
10. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Campbell RJ; Bronskill SE; Bell CM; Paterson JM; Whitehead M; Gill SS Arch Ophthalmol; 2010 Mar; 128(3):359-62. PubMed ID: 20212208 [TBL] [Abstract][Full Text] [Related]
13. Focal macular electroretinograms after intravitreal injections of bevacizumab for age-related macular degeneration. Iwata E; Ueno S; Ishikawa K; Ito Y; Uetani R; Piao CH; Kondo M; Terasaki H Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4185-90. PubMed ID: 22618591 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal injections: a review of the evidence for best practice. Fagan XJ; Al-Qureshi S Clin Exp Ophthalmol; 2013 Jul; 41(5):500-7. PubMed ID: 23078366 [TBL] [Abstract][Full Text] [Related]
16. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting. Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735 [TBL] [Abstract][Full Text] [Related]